Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

    • They remember fishing in the lake. [undo]
    • Salbutamol (SABA) [undo]
    • Costas and his father discuss at the park. [undo]
    • Pioglitazone [undo]
    • Decision: Initial Approach [undo]
    • Κλινική εξέταση [undo]
    • Amnestic exam [undo]
    • Ο2 & iv υγρά & σαλβουταμόλη. και αέρια αίματος [undo]
    • Use open-ended questions and clarify priority symptoms (pain, discharge, fever). [undo]
    • Ο2 & iv υγρά & σαλβουταμόλη. [undo]
    • Presentation [undo]
    • Grapefruit-thiazide diuretic interaction [undo]
    • Increased entry of fatty acids into adipocytes [undo]
    • Decreased entry of glucose into muscle cells [undo]
    • Εργαστηριακά 2 [undo]
    • Guanethidine [undo]
    • I will independently adjust the dose of warfarin (decrease/increase)This is a wrong response that could lead to potentially harmful results to the health [undo]
    • Pioglitazone [undo]
    • Start with instructions about vitamin and mineral supplements [undo]
    • Έναρξη [undo]
    • Empagliflozin [undo]

    Map: Michael Green_GEMD_2 (1116)
    Node: 21112
    Score:

    reset

    OpenLabyrinth
    OpenLabyrinth is an open source educational pathway system

    Review your pathway